Intercept Pharmaceuticals' PIPE Round

Intercept Pharmaceuticals raised a round of funding on April 05, 2018.

Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease utilizing expertise in bile acid chemistry. The…

Articles about Intercept Pharmaceuticals' PIPE Round: